Elidel, promising option for long-term treatment of atopic dermatitis

Published: 2004-09-02 06:58:00

Updated: 2004-09-02 06:58:00

Elidel (pimecrolimus) cream holds promise as a value long-term treatment option for patients with atopic dermatitis, said Professor Thomas Luger, Department of Dermatology of Minster University, Germany.

Presenting the Elidel data at the Korean Dermatological Association symposium on atopic de...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK